Finally, the cleavage of Plk1 with BI-2536 and Volasertib, but not Rigosertib was confirmed in primary myeloid cells from one CML patient (Supplementary Figure 7). Here, PLK1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.